Abstract: A control unit and a method are provided for controlling a riding function of a two-wheeled vehicle. The riding function is configured to guide the two-wheeled vehicle longitudinally and/or transversely in an automated manner. The control unit is configured to detect that the riding function is activated in order to bring about automated longitudinal and/or transverse guidance by the riding function, to determine that dynamic adaptation of the riding function is requested by the driver, and in response thereto, to initiate that, with the riding function being active, a control parameter influencing the dynamics of the riding function is adapted on the basis of the requested dynamic adaptation.

Abstract: A stand structure includes a vertically aligned central pillar that is not connected to a subsurface and an upper bearing surface for a construction. At least three foot elements are disposed around the central pillar and configured to be connected to the subsurface. Each of the foot elements is connected to at least one upper radial strut and at least one lower radial strut. Each of the struts has a central longitudinal axis, an upper attachment to the central pillar and a lower attachment to a respective one of the foot elements. The central longitudinal axes of each of the upper radial struts has a convexly curved profile beginning at a respective one of the upper attachments. At least one tensile element is disposed so as to compensate buckling forces for each of the upper radial struts.

Abstract: The invention relates to novel markers of vascular inflammation and combinations thereof as diagnostic and prognostic tools in patients with cardiovascular diseases. The markers also act as tools that facilitate the selection of active ingredients for the treatment of such diseases, and finally act as starting points for the treatment of cardiovascular diseases. Furthermore, the invention relates to the creation of an individual risk profile of negative events that are associated with the progression of arteriosclerosis.

Abstract: A stand structure includes a vertically aligned central pillar that is not connected to a subsurface and an upper bearing surface for a construction. At least three foot elements are disposed around the central pillar and configured to be connected to the subsurface. Each of the foot elements is connected to at least one upper radial strut and at least one lower radial strut. Each of the struts has a central longitudinal axis, an upper attachment to the central pillar and a lower attachment to a respective one of the foot elements. The central longitudinal axes of each of the upper radial struts has a convexly curved profile beginning at a respective one of the upper attachments. At least one tensile element is disposed so as to compensate buckling forces for each of the upper radial struts.

Abstract: The invention relates to novel markers of vascular inflammation and combinations thereof as diagnostic and prognostic tools in patients with cardiovascular diseases. The markers also act as tools that facilitate the selection of active ingredients for the treatment of such diseases, and finally act as starting points for the treatment of cardiovascular diseases. Furthermore, the invention relates to the creation of an individual risk profile of negative events that are associated with the progression of arteriosclerosis.

Abstract: The invention relates to novel markers of vascular inflammation and combinations thereof as diagnostic and prognostic tools in patients with cardiovascular diseases. The markers also act as tools that facilitate the selection of active ingredients for the treatment of such diseases, and finally act as starting points for the treatment of cardiovascular diseases. Furthermore, the invention relates to the creation of an individual risk profile of negative events that are associated with the progression of arteriosclerosis.

Abstract: The present invention concerns methods for diagnosing myocardial infarction, for performing risk stratification of myocardial infarction, for making a prognosis of a disease course in a myocardial infarction patient, for identifying a patient with elevated risk of myocardial infarction, or combinations thereof, wherein a determination of at least three markers is performed on a patient sample. Furthermore, kits for performing the methods are provided.

Abstract: The present invention concerns methods for diagnosing myocardial infarction, for performing risk stratification of myocardial infarction, for making a prognosis of a disease course in a myocardial infarction patient, for identifying a patient with elevated risk of myocardial infarction, or combinations thereof, wherein a determination of at least three markers is performed on a patient sample. Furthermore, kits for performing the methods are provided.

Abstract: A method of determining structural data of a prototype for a lightweight technical structure by selecting shell architectures of natural bio-mineralized unicellular organisms in accordance with an aspect set very closely adapted to the lightweight structure to be produced and by directly copying and thereafter scaling their structural data to the prototype before optimizing the Prototype by perfect adaptation to the lightweight structure to be produced.

Abstract: A lightweight construction includes a superficial surface and a regularly, periodically configured supporting structure that mechanically reinforces the superficial surface. The supporting structure has fractal structuring into at least two fractal planes which have integrated fluid transitions therebetween.

Abstract: A method of determining structural data of a prototype for a lightweight technical structure by selecting shell architectures of natural bio-mineralized unicellular organisms in accordance with an aspect set very closely adapted to the lightweight structure to be produced and by directly copying and thereafter scaling their structural data to the prototype before optimizing the Prototype by perfect adaptation to the lightweight structure to be produced.

Abstract: The invention relates to novel markers of vascular inflammation and combinations thereof as diagnostic and prognostic tools in patients with cardiovascular diseases. The markers also act as tools that facilitate the selection of active ingredients for the treatment of such diseases, and finally act as starting points for the treatment of cardiovascular diseases. Furthermore, the invention relates to the creation of an individual risk profile of negative events that are associated with the progression of arteriosclerosis.